tiprankstipranks
Ensysce Biosciences (ENSC)
NASDAQ:ENSC
US Market
ENSC
Ensysce Biosciences
RESEARCH TOOLSreports
Want to see ENSC full AI Analyst Report?

Ensysce Biosciences (ENSC) Financial Statements

302 Followers

Ensysce Biosciences Financial Overview

Ensysce Biosciences's market cap is currently $4.96M. The company's EPS TTM is $-0.75; its P/E ratio is -0.21; Ensysce Biosciences is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Mar 22
Income Statement
Total Revenue$ 5.07M$ 5.21M$ 2.23M$ 2.52M$ 3.53M
Gross Profit$ 0.00$ -2.01M$ -5.36M$ -17.31M$ 3.53M
Operating Income$ -10.24M$ -6.73M$ -10.72M$ -24.22M$ -19.87M
EBITDA$ -10.15M$ -6.73M$ -10.72M$ -24.22M$ -25.93M
Net Income$ -10.18M$ -7.99M$ -10.61M$ -24.17M$ -29.08M
Balance Sheet
Cash & Short-Term Investments$ 4.31T$ 3.50M$ 1.12M$ 3.15M$ 12.26M
Total Assets$ 7.45T$ 5.60M$ 2.71M$ 5.89M$ 16.42M
Total Debt$ 306.71B$ 301.66K$ 854.70K$ 4.43M$ 17.21M
Net Debt$ -4.00T$ -3.20M$ -268.91K$ 1.29M$ 4.95M
Total Liabilities$ 4.57T$ 2.22M$ 3.36M$ 9.91M$ 24.58M
Stockholders' Equity$ 3.21T$ 3.71M$ -322.86K$ -3.71M$ -7.88M
Cash Flow
Free Cash Flow$ -7.81T$ -7.50T$ -10.78M$ -17.89M$ -8.24M
Operating Cash Flow$ -7.81T$ -7.50T$ -10.78M$ -17.89M$ -8.24M
Investing Cash Flow$ -123.64B$ 0.00$ 0.00$ 4.50K$ 0.00
Financing Cash Flow$ 8.74T$ 9.88T$ 8.76M$ 8.77M$ 20.31M
Currency in USD

Ensysce Biosciences Earnings and Revenue History

Income Statement >

Ensysce Biosciences Debt to Assets

Balance Sheet >

Ensysce Biosciences Cash Flow

Cash Flow >

Ensysce Biosciences Forecast EPS vs Actual EPS

Earnings >